ATE163130T1 - Stabilisierte pvp-i lösungen - Google Patents

Stabilisierte pvp-i lösungen

Info

Publication number
ATE163130T1
ATE163130T1 AT92106500T AT92106500T ATE163130T1 AT E163130 T1 ATE163130 T1 AT E163130T1 AT 92106500 T AT92106500 T AT 92106500T AT 92106500 T AT92106500 T AT 92106500T AT E163130 T1 ATE163130 T1 AT E163130T1
Authority
AT
Austria
Prior art keywords
solution
pvp
solutions
standards
effective amount
Prior art date
Application number
AT92106500T
Other languages
English (en)
Inventor
Dileep Bhagwat
Benjamin Oshlack
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE163130T1 publication Critical patent/ATE163130T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT92106500T 1991-07-16 1992-04-15 Stabilisierte pvp-i lösungen ATE163130T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/730,462 US5126127A (en) 1991-07-16 1991-07-16 Stabilized PVP-I solutions

Publications (1)

Publication Number Publication Date
ATE163130T1 true ATE163130T1 (de) 1998-02-15

Family

ID=24935466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92106500T ATE163130T1 (de) 1991-07-16 1992-04-15 Stabilisierte pvp-i lösungen

Country Status (16)

Country Link
US (1) US5126127A (de)
EP (1) EP0526695B1 (de)
JP (1) JP3531945B2 (de)
KR (1) KR100191873B1 (de)
AT (1) ATE163130T1 (de)
AU (1) AU646745B2 (de)
CA (1) CA2062001C (de)
DE (1) DE69224416T2 (de)
DK (1) DK0526695T3 (de)
EG (1) EG19995A (de)
ES (1) ES2111581T3 (de)
FI (1) FI114443B (de)
IE (1) IE920796A1 (de)
IL (1) IL101079A (de)
NO (1) NO306379B1 (de)
ZA (1) ZA921365B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2685892A (en) * 1991-10-08 1993-05-03 Isp Investments Inc. Method of treating blood
GB9306296D0 (en) * 1993-03-26 1993-05-19 Diversey Corp Improved iodophors,production and use thereof
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
JP3108262B2 (ja) * 1993-12-22 2000-11-13 明治製菓株式会社 研磨剤を含有しない口腔用半練状製剤
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
DE60315955T2 (de) 2003-05-19 2008-06-05 Euro-Celtique S.A. Trockene liposomale PVP-Jod Zubereitungen
US20050262811A1 (en) * 2004-05-27 2005-12-01 Mahmood Mohiuddin Sterilization process for iodine-containing antimicrobial topical solutions
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
AU2013203462B2 (en) * 2006-03-14 2016-08-04 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
AU2016253668B2 (en) * 2006-03-14 2018-12-06 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
JP5083502B2 (ja) * 2006-12-25 2012-11-28 ライオン株式会社 眼科用組成物
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
CN102118973A (zh) * 2008-06-12 2011-07-06 前瞻生物治疗公司 一种眼科组合物中新的防腐剂替代物聚维酮碘
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
JP5367597B2 (ja) 2010-01-18 2013-12-11 株式会社オフテクス コンタクトレンズ洗浄用有核錠及びそれを含むコンタクトレンズ洗浄用製剤、並びにコンタクトレンズ洗浄方法
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
TW201808311A (zh) * 2011-09-16 2018-03-16 遠景生物製藥股份有限公司 安定之普維酮-碘組成物
BR112015005008B1 (pt) 2012-09-12 2022-04-19 Novaliq Gmbh Composições de alcano semifluorado
CN104619314B (zh) 2012-09-12 2017-09-22 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
US9770466B2 (en) 2015-07-02 2017-09-26 Veloce Biopharma, Llc Ophthalmic composition and methods of use
US20180200289A1 (en) * 2015-07-02 2018-07-19 Veloce Biopharma, Llc Novel ophthalmic composition and methods of use
CN108348777B (zh) 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
EP3612228B1 (de) 2017-04-21 2023-08-23 Dermaliq Therapeutics, Inc. Jodzusammensetzungen
IT201700068170A1 (it) * 2017-06-20 2018-12-20 Iromed Group S R L Composizione disinfettante per uso oftalmico
WO2019040051A1 (en) * 2017-08-22 2019-02-28 Veloce Biopharma, Llc NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
JP6941889B2 (ja) 2017-09-02 2021-09-29 アイビュー セラピューティクス、インコーポレイテッド インサイチュゲル形成医薬組成物および副鼻腔疾患のためのその使用
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
EP3784246A1 (de) 2018-04-27 2021-03-03 Novaliq GmbH Ophthalmische zusammensetzungen mit tafluprost zur behandlung von glaukomen
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物
KR20200081160A (ko) 2018-12-27 2020-07-07 유한회사 플루켐 염화나트륨 함유 포비돈 요오드 안정 조성물 및 방법
PL3980031T3 (pl) 2019-06-10 2026-04-20 Firebrick Pharma Limited Zapobieganie zakażeniom wysoce patogennymi wirusami poprzez miejscowe stosowanie jodopowidonu na błony śluzowe
EP4013461A4 (de) * 2019-08-18 2023-08-23 IVIEW Therapeutics, Inc. Stabile pharmazeutische artikel mit verdünnten povidon-iod-formulierungen
CA3180198A1 (en) * 2020-06-10 2021-12-16 Peter Molloy Improved virucidal formulations
AU2021203846B2 (en) * 2021-06-10 2022-11-24 Firebrick Pharma Limited Virucidal formulations containing povidone-iodine
KR102434736B1 (ko) 2021-11-04 2022-08-23 (주)씨에스하이테크플러스 신재생에너지를 이용한 에너지자립형 냉난방 시스템 및 방법
KR102917044B1 (ko) * 2023-06-22 2026-01-23 주식회사 퍼슨헬스케어 세정용 포비돈요오드 조성물 및 그 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
SE7902893L (sv) * 1979-04-02 1980-10-03 Astra Chem Prod Ab Desinfektionsmedel
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4526751A (en) * 1983-12-09 1985-07-02 Gartner William J Germicidal solutions effective for solid surface disinfection
EP0323522A4 (de) * 1987-07-07 1989-08-30 Santen Pharmaceutical Co Ltd Kunstträne.
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
EP0348527B1 (de) * 1987-12-25 1993-06-23 Santen Pharmaceutical Co., Ltd. Antiallergische augentropfen
US4939272A (en) * 1989-05-05 1990-07-03 Gaf Chemicals Corporation Water soluble complexes of polyvinylpyrrolidone, hydrogen chloride and iodine and process for making the same
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.

Also Published As

Publication number Publication date
CA2062001C (en) 1999-03-02
NO922793L (no) 1993-01-18
FI922906A0 (fi) 1992-06-22
JP3531945B2 (ja) 2004-05-31
NO922793D0 (no) 1992-07-15
DE69224416T2 (de) 1998-07-30
JPH0570356A (ja) 1993-03-23
DE69224416D1 (de) 1998-03-19
KR930001914A (ko) 1993-02-22
NO306379B1 (no) 1999-11-01
IL101079A0 (en) 1992-11-15
AU1942792A (en) 1994-01-13
EP0526695A1 (de) 1993-02-10
IE920796A1 (en) 1993-01-27
KR100191873B1 (ko) 1999-06-15
US5126127A (en) 1992-06-30
ZA921365B (en) 1992-11-25
AU646745B2 (en) 1994-03-03
CA2062001A1 (en) 1993-01-17
IL101079A (en) 1997-01-10
FI114443B (fi) 2004-10-29
DK0526695T3 (da) 1998-09-23
EG19995A (en) 1997-01-30
FI922906L (fi) 1993-01-17
EP0526695B1 (de) 1998-02-11
ES2111581T3 (es) 1998-03-16

Similar Documents

Publication Publication Date Title
DE69224416D1 (de) Stabilisierte PVP-I Lösungen
AU7004387A (en) New pharmaceutical preparations with extended release
DE3382637D1 (de) Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
AU1022588A (en) Ointment base and ointment
DE68903701D1 (de) Kontaktlinsendesinfizierungs-set.
EP0371283A3 (de) Stabilisierung von verpacktem Jodophor und Verringerung des Jodverlusts durch die Verpackung
FI902713A0 (fi) Menetelmä stabiilin karboplatiinivesiliuoksen valmistamiseksi
DE69011500D1 (de) Zusammensetzung um Flüssigkeiten zu gelieren.
DE69106990D1 (de) Poviden-Jod enthaltende pharmazeutische Zubereitung.
DE69122901D1 (de) Jod enthaltende pharmazeutische Zusammensetzung
AU8295587A (en) Nasal solutions
CA2119918A1 (en) Iodophors, Production and Use Thereof
DK0397147T3 (da) Stabile opløsninger af rebeccamycinanalog og fremstilling deraf
DE69613803D1 (de) Augentropfen insbesonders zur Behandlung des trockenen Auges
DK1126848T3 (da) Plastikbeholder indeholdende stabiliserende lægemiddelformuleringer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee